Statement of Comprehensive Income
Comprehensive income is the change in equity (net assets) of a business enterprise during a period from transactions and other events and circumstances from non-owners sources. It includes all changes in equity during a period except those resulting from investments by owners and distributions to owners.
Paying user area
Try for free
Abiomed Inc. pages available for free this week:
- Cash Flow Statement
- Common-Size Balance Sheet: Assets
- Analysis of Liquidity Ratios
- Analysis of Solvency Ratios
- DuPont Analysis: Disaggregation of ROE, ROA, and Net Profit Margin
- Enterprise Value to EBITDA (EV/EBITDA)
- Enterprise Value to FCFF (EV/FCFF)
- Price to Book Value (P/BV) since 2005
- Analysis of Revenues
- Analysis of Debt
The data is hidden behind: . Unhide it.
Get full access to the entire website from $10.42/mo, or
get 1-month access to Abiomed Inc. for $22.49.
This is a one-time payment. There is no automatic renewal.
We accept:
Based on: 10-K (reporting date: 2022-03-31), 10-K (reporting date: 2021-03-31), 10-K (reporting date: 2020-03-31), 10-K (reporting date: 2019-03-31), 10-K (reporting date: 2018-03-31), 10-K (reporting date: 2017-03-31).
- Net Income
- Net income exhibited a generally increasing trend from 2017 through 2019, rising sharply from $52,116 thousand in 2017 to a peak of $259,016 thousand in 2019. However, in 2020, net income declined to $203,009 thousand, followed by a moderate recovery to $225,525 thousand in 2021. In 2022, net income decreased again to $136,505 thousand, indicating increased volatility and a downward shift relative to the earlier peak.
- Foreign Currency Translation Gains (Losses)
- This component showed significant fluctuations over the period. The value changed from a loss of $5,855 thousand in 2017 to a gain of $16,862 thousand in 2018, followed by alternating losses and gains in subsequent years. Notably, losses occurred in 2019, 2020, and 2022, with gains in 2021. The inconsistent pattern suggests exposure to foreign exchange volatility without a clear directional trend.
- Unrealized Gains (Losses) on Derivative Instruments
- Data for this item is available only from 2020 onwards. In 2020, there was a gain of $3,999 thousand. This was followed by losses in 2021 and 2022, with values of $2,095 thousand and $1,779 thousand respectively. This suggests increasing unfavorable movements in derivative valuations during the later years.
- Net Unrealized Gains (Losses) on Marketable Securities, Net of Tax
- These figures show variability without a consistent trend. Initially recording a small loss in 2017 (-$211 thousand) and a larger loss in 2018 (-$460 thousand), the item turned positive in 2019 and 2020 with gains of $946 thousand and $1,333 thousand respectively. However, substantial losses occurred in 2021 and 2022, especially a sharp decline to -$8,092 thousand in 2022, indicating a deterioration in marketable securities' valuation during the recent years.
- Other Comprehensive Income (Loss)
- Other comprehensive income mirrored the volatility seen in foreign currency translations and marketable securities. The item swung from a loss of $6,066 thousand in 2017 to a gain of $16,402 thousand in 2018, then back to losses predominantly from 2019 onward, culminating in a significant loss of $15,715 thousand in 2022. This reflects considerable fluctuations in components typically excluded from net income but affecting total comprehensive results.
- Comprehensive Income
- Comprehensive income generally followed the trend of net income, increasing from $46,050 thousand in 2017 to a peak of $248,531 thousand in 2019. It declined slightly in 2020 to $206,509 thousand but remained above 2020 levels in 2021 at $225,269 thousand. In 2022, comprehensive income decreased more sharply to $120,790 thousand. The overall trajectory suggests that while core earnings performance was strong through 2019, other factors accounted for increased volatility in total comprehensive income in recent years.